Bide Pharmatech Co (SHSE:688073) ROCE % : 6.09% (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Bide Pharmatech Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Bide Pharmatech Co's annualized ROCE % for the quarter that ended in Mar. 2024 was 6.09%.

Bide Pharmatech Co ROCE % Historical Data

The historical data trend for Bide Pharmatech Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bide Pharmatech Co ROCE % Chart

Bide Pharmatech Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

9.64

27.50

22.10

12.57

6.05

Bide Pharmatech Co Quarterly Data
	Dec18	Dec19	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial											8.23	10.34	6.62	-0.93	6.09

Bide Pharmatech Co ROCE % Calculation

Bide Pharmatech Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	128.527	/	( ( (2359.206 - 249.071)	+	(2415.028 - 274.97) )	/ 2 )
	=	128.527	/	( (2110.135	+	2140.058)	/ 2 )
	=	128.527	/	2125.0965
	=	6.05 %

Bide Pharmatech Co's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	128.668	/	( ( (2415.028 - 274.97)	+	(2381.92 - 296.518) )	/ 2 )
	=	128.668	/	( ( 2140.058	+	2085.402 )	/ 2 )
	=	128.668	/	2112.73
	=	6.09 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Bide Pharmatech Co (SHSE:688073) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Bide Pharmatech Co ROCE % Related Terms

Thank you for viewing the detailed overview of Bide Pharmatech Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Bide Pharmatech Co (SHSE:688073) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bide Pharmatech Co Ltd (SHSE:688073) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

No. 128, Xiangyin Road, Room 101, Block A, Building 11, Yangpu District, Shanghai, CHN, 200433

Website

https://www.bidepharmatech.com

Bide Pharmatech Co Ltd is engaged in the research and development, design, production and sales of drug molecular building blocks.

Bide Pharmatech Co (SHSE:688073) Headlines

No Headlines